| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.57B | +10.2% |
| Cost of Revenue | $744.6M | +13.8% |
| Gross Profit | $1.82B | +8.8% |
| R&D Expense | $412.4M | +51.9% |
| SG&A Expense | $312.3M | +10.5% |
| Operating Income | -$658.6M | -241.4% |
| Interest Expense | $14.2M | +43.3% |
| Pre-tax Income | -$662.0M | -240.4% |
| Income Tax | $32.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $921.3M | +18.1% |
| Accounts Receivable | $27.9M | +2.3% |
| Current Assets | $1.51B | +12.8% |
| Total Assets | $2.63B | -31.2% |
| Current Liabilities | $631.8M | +2.6% |
| Long-term Debt | $2.28B | +0.2% |
| Total Liabilities | $3.18B | -0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $683.6M | +4.9% |
| Capital Expenditures | $10.2M | -9.0% |
| Investing Cash Flow | -$30.0M | +98.1% |
| Financing Cash Flow | -$506.5M | -211.9% |
| Free Cash Flow | $673.4M | +5.2% |
| +247.9% |
| Net Income | -$694.3M | -240.7% |
| EPS (Basic) | -$5.48 | -241.2% |
| EPS (Diluted) | -$5.48 | -261.2% |
| Stockholders' Equity |
| -$547.3M |
| -187.1% |